| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/07/2011 | CN101332269B Traditional Chinese medicine propellant for treating pharyngitis and preparation method thereof |
| 09/07/2011 | CN101317824B Levodropropizine lozenge and preparation method thereof |
| 09/07/2011 | CN101314035B Uses of biological polyoses microcapsule |
| 09/07/2011 | CN101278928B Medicament composition containing levocarnitine or its derivatives and use thereof |
| 09/07/2011 | CN101259125B Anethol trithione injection emulsion and preparation thereof |
| 09/07/2011 | CN101239125B Capable of improving endocrine function |
| 09/07/2011 | CN101234139B Proprietary Chinese medicine for curing common cold and preparation thereof |
| 09/07/2011 | CN101234103B Total coumarin angelica dahurica composition |
| 09/07/2011 | CN101194979B Powder medicament for treating herpes stomatitis |
| 09/07/2011 | CN101175474B Methods of reducing microbial contamination |
| 09/07/2011 | CN101172096B Target controlling and releasing system for magnetic microsphere carrier in bipolar precipitous magnetic field impulse hunting magnetic field |
| 09/07/2011 | CN101161247B Potassium muriate stomach-inner retention floationg type slow release tablet prepared with shuck powder as carrier |
| 09/07/2011 | CN101151020B Adjuvanting material |
| 09/07/2011 | CN101134080B Compound traditional Chinese powder medicine for treating acute mastitis for cows |
| 09/07/2011 | CN101134018B Fenofibrate pellet and method for preparing the same |
| 09/07/2011 | CN101120912B Ftibamzone chrisma with PEG-400 as co-solvent |
| 09/07/2011 | CN101068534B Pharmaceutical compositions comprising levetiracetam and process for their preparation |
| 09/07/2011 | CN101066355B Chinese medicine prepn for treating toothache and its prepn process |
| 09/07/2011 | CN101011470B Traditional Chinese medicine compound composition for treating hepatitis |
| 09/06/2011 | US8014872 System and apparatus for controlled activation of acute use medical devices |
| 09/06/2011 | US8013017 Dermatological compositions and methods |
| 09/06/2011 | US8013013 Formulation and delivery method to enhance antioxidant potency of vitamin E |
| 09/06/2011 | US8012996 Methods and composition for inhibition of angiogenesis |
| 09/06/2011 | US8012990 Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia |
| 09/06/2011 | US8012935 Oligopeptide for blocking cancer |
| 09/06/2011 | US8012933 Use of the cathelicidin LL-37 and derivatives therof for wound healing |
| 09/06/2011 | US8012508 Method of targeting sustained release formulations of therapeutic agents to treat lung diseases |
| 09/06/2011 | US8012507 High-pressure gas spraying and/or near supercritical spraying of formulations followed by drying in a stream of conditioned gas to form stable powder particles; for storage of proteins and live viruses, vaccines at temperatures above freezing |
| 09/06/2011 | US8012505 A non-compressed, fast-dispersing solid dosage form suitable for oromucosal administration; maltodextrin having a dextrose equivalent (DE) of between 1 and 20, sorbitol, and the drug; improved storage stability and mechanical strength |
| 09/06/2011 | US8012504 Sustained release portion of unit dose containing guaifenesin, dextromethorphan and a release-delaying matrix contains a hydrophilic polymer and a water insoluble polymer, immediate release portion containing guaifenesin |
| 09/06/2011 | US8012503 Administering propranolol or a derivative across a mucosal membrane in combination with a buffering agent (phosphate buffer) to provide a pH of 7.6 at the membrane; sublingual; cardiovascular disorders |
| 09/06/2011 | US8012498 Topical gel formulation comprising organophosphate insecticide and preparation thereof |
| 09/06/2011 | US8012497 Cleansing lotion with moisturising, protecting and odor controlling agents and cloth comprising said lotion |
| 09/06/2011 | US8012496 Gastric retention controlled drug delivery system |
| 09/06/2011 | US8012495 Lotion-treated tissue and towel |
| 09/06/2011 | US8012494 at least one non-ionic or zwitterionic surfactant and dispersant; improves the efficacy and/or potency of the lipase inhibitor; inter-subject variability in efficacy and/or potency is reduced, as well as the frequency and intensity of side effects |
| 09/06/2011 | US8012463 Coordination complex of diaminocyclohexaneplatinum(II) with block copolymer containing poly(carboxylic acid) segment and antitumor agent comprising the same |
| 09/06/2011 | US8012460 Mixture of hydroxyethyl cellulose, xanthan gum and carbopol" |
| 09/06/2011 | US8012459 Fine-texture cosmetic composition |
| 09/06/2011 | US8012454 Embolization |
| 09/06/2011 | US8012382 Molded waveguides |
| 09/06/2011 | US8012119 Medication delivery system and monitor |
| 09/06/2011 | CA2656181C Compressed preparation of compositions comprising olmesartan medoxomil |
| 09/06/2011 | CA2519946C Temporary embolization using inverse thermosensitive polymers |
| 09/06/2011 | CA2514570C Taste-masking coated particles, process for the preparation thereof and orodispersible tablets containing said coated particles |
| 09/06/2011 | CA2506997C Controlled drug delivery using polymer macromolecules to retard drug elution |
| 09/06/2011 | CA2445200C Medicinal tablet with prolonged release of the active principle |
| 09/06/2011 | CA2411882C Solid valsartan pharmaceutical compositions |
| 09/06/2011 | CA2410025C Use of biguanide derivatives for making a medicine having a wound healing effect |
| 09/06/2011 | CA2402774C Microsphere hydrogel biomedical articles |
| 09/06/2011 | CA2396148C Improved pediatric formula and methods for providing nutrition and improving tolerance |
| 09/06/2011 | CA2363123C Solid oral dosage form containing an enhancer |
| 09/02/2011 | WO2010097344A1 Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin |
| 09/02/2011 | CA2784516A1 Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin |
| 09/01/2011 | WO2011106729A2 Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents |
| 09/01/2011 | WO2011106702A2 Sustained delivery of therapeutic agents to an eye compartment |
| 09/01/2011 | WO2011106478A2 Apixaban formulations |
| 09/01/2011 | WO2011106424A2 Feline stimulant and method of manufacture |
| 09/01/2011 | WO2011106376A2 Use of microvesicles in the treatment of medical conditions |
| 09/01/2011 | WO2011106309A2 Materials and methods for mri contrast agents and drug delivery |
| 09/01/2011 | WO2011106026A1 Emollient foams for treatment of dermatoses |
| 09/01/2011 | WO2011105975A1 Dry powder formulations administered by the inhalation route comprising a combination of tiotropium bromide, salmeterol xynafoate and fluticasone propionate. |
| 09/01/2011 | WO2011105835A2 Method and apparatus for preparing novel liposome |
| 09/01/2011 | WO2011105736A2 Surface-modified tantalum oxide nanoparticles, preparation method thereof, and contrast medium for x-ray computed tomography and highly dielectric thin film using same |
| 09/01/2011 | WO2011105539A1 Coated solid preparation |
| 09/01/2011 | WO2011105534A1 Hard capsule and method for producing same |
| 09/01/2011 | WO2011105520A1 Composite body for antigen or drug delivery |
| 09/01/2011 | WO2011105492A1 Transdermal preparation |
| 09/01/2011 | WO2011105486A1 Adhesive patch |
| 09/01/2011 | WO2011105458A1 Adhesive patch containing bisoprolol |
| 09/01/2011 | WO2011105457A1 Adhesive skin patch |
| 09/01/2011 | WO2011104901A1 Anti-trichophyton agent, therapeutic material for skin diseases caused by trichophyton bacterium which comprises same, and therapeutic tool for the diseases |
| 09/01/2011 | WO2011104652A2 Veterinary compositions |
| 09/01/2011 | WO2011104588A2 Solid pharmaceutical formulations of ramipril and amlodipine besylate, and their preparation |
| 09/01/2011 | WO2011104557A1 Protein formulations |
| 09/01/2011 | WO2011104360A1 Formulation of compositions for the treatment of inflammatory conditions |
| 09/01/2011 | WO2011104315A2 Immunoglobulin preparation and storage system for an immunoglobulin preparation |
| 09/01/2011 | WO2011104275A1 Formulations for oral delivery of adsorbents in the gut |
| 09/01/2011 | WO2011104234A2 Multiplication of the efficacy of anti-infectious agents by a composition further comprising a dispersing agent together with a metal activating agent |
| 09/01/2011 | WO2011104037A2 Process for preparing a ready-to-use product which can be metered |
| 09/01/2011 | WO2011103920A2 Pharmaceutical or neutraceutical formulation |
| 09/01/2011 | WO2011103806A1 Oral microemulsion of elemene |
| 09/01/2011 | WO2011103789A1 Capsule of complex danshen drop pill |
| 09/01/2011 | WO2011103774A1 Pharmaceutical composition and use thereof in manufacturing medicaments for treating respiratory diseases |
| 09/01/2011 | WO2011103718A1 Controlled (sustained) release preparation containing quetiapine and preparation method and use thereof |
| 09/01/2011 | WO2011080647A3 Gelatin capsules and gelatin compositions for forming capsule coating |
| 09/01/2011 | WO2011063952A8 Formulations of bisphosphonates and vitamin d suitable for intermittent intramuscular and subcutaneous administration |
| 09/01/2011 | WO2011061616A3 Extended release compositions containing tolterodine and process for preparing the same |
| 09/01/2011 | WO2011059931A9 Nanosuspension of a poorly soluble drug made by microfluidization process |
| 09/01/2011 | WO2011039768A3 Pharmaceutical compositions for reducing alcohol-induced dose dumping |
| 09/01/2011 | WO2011034396A3 Solid dispersion comprising a fibrate drug, and method for preparing the solid dispersion |
| 09/01/2011 | WO2011031116A3 Pad for herbal medicine in which release of medicinal ingredient can be controlled, and manufacturing method thereof |
| 09/01/2011 | WO2010119367A3 A medicinal cream made using hydrocortisone acetate and a process to make the same |
| 09/01/2011 | WO2010114982A3 Lyophilization cakes of proteasome inhibitors |
| 09/01/2011 | WO2010050794A8 Cardioprotective effects of nutraceuticals isolated from nigella sativa seeds |
| 09/01/2011 | US20110213468 Silane Coating Process for High Alkali Bioactive Glasses |
| 09/01/2011 | US20110213293 Ligands to radiation-induced molecules |
| 09/01/2011 | US20110213193 Magnetic Nanodelivery of Therapeutic Agents Across the Blood Brain Barrier |
| 09/01/2011 | US20110213192 Inorganic Nanoparticles of High Density to Destroy Cells In-Vivo |
| 09/01/2011 | US20110213014 Compositions and methods for topical delivery of oligonucleotides |